MHIC
DXCM icon

Marble Harbor Investment Counsel’s DexCom DXCM Stock Holding History

Marble Harbor Investment Counsel’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.85M Buy
125,012
+1,440
+1% +$100K 0.85% 40
2025
Q4 		$8.2M Sell
123,572
-39,376
-24% -$2.55M 0.88% 35
2025
Q3 		$11M Buy
162,948
+4,293
+3% +$340K 1.15% 26
2025
Q2 		$13.8M Sell
158,655
-6,341
-4% -$497K 1.51% 21
2025
Q1 		$11.3M Sell
164,996
-2,587
-2% -$211K 1.27% 25
2024
Q4 		$13M Buy
167,583
+7,674
+5% +$568K 1.44% 21
2024
Q3 		$10.7M Buy
159,909
+12,735
+9% +$1.05M 1.17% 26
2024
Q2 		$16.7M Sell
147,174
-222
-0.2% -$28.1K 1.96% 14
2024
Q1 		$20.4M Buy
147,396
+2,120
+1% +$266K 2.36% 12
2023
Q4 		$18M Buy
145,276
+1,375
+1% +$140K 2.22% 12
2023
Q3 		$13.4M Buy
143,901
+1,200
+0.8% +$135K 1.76% 17
2023
Q2 		$18.3M Buy
142,701
+165
+0.1% +$20K 2.31% 12
2023
Q1 		$16.6M Sell
142,536
-145
-0.1% -$16.2K 2.14% 13
2022
Q4 		$16.2M Buy
142,681
+680
+0.5% +$74.7K 2.18% 15
2022
Q3 		$11.4M Buy
142,001
+983
+0.7% +$83.3K 1.75% 19
2022
Q2 		$10.5M Buy
141,018
+3,098
+2% +$283K 1.6% 20
2022
Q1 		$17.6M Buy
137,920
+1,520
+1% +$166K 2.19% 13
2021
Q4 		$18.3M Sell
136,400
-5,108
-4% -$734K 2.13% 16
2021
Q3 		$19.3M Sell
141,508
-672
-0.5% -$84.7K 2.61% 11
2021
Q2 		$15.2M Buy
142,180
+7,440
+6% +$714K 1.96% 16
2021
Q1 		$12.1M Buy
134,740
+5,460
+4% +$513K 1.66% 20
2020
Q4 		$11.9M Buy
129,280
+12,372
+11% +$1.1M 1.76% 19
2020
Q3 		$12M Sell
116,908
-580
-0.5% -$60.6K 1.97% 19
2020
Q2 		$11.9M Sell
117,488
-23,620
-17% -$2.11M 2.07% 16
2020
Q1 		$9.5M Buy
141,108
+740
+0.5% +$46K 1.87% 18
2019
Q4 		$7.68M Sell
140,368
-232
-0.2% -$11K 1.21% 28
2019
Q3 		$5.25M Sell
140,600
-3,360
-2% -$131K 0.93% 36
2019
Q2 		$5.39M Buy
143,960
+7,800
+6% +$245K 0.93% 37
2019
Q1 		$4.05M Sell
136,160
-3,200
-2% -$112K 0.72% 42
2018
Q4 		$4.17M Buy
139,360
+720
+0.5% +$22.8K 0.83% 39
2018
Q3 		$4.96M Sell
138,640
-400
-0.3% -$12.4K 0.88% 37
2018
Q2 		$3.3M Sell
139,040
-220
-0.2% -$4.66K 0.63% 45
2018
Q1 		$2.58M Buy
139,260
+5,480
+4% +$81K 0.51% 53
2017
Q4 		$1.92M Sell
133,780
-17,980
-12% -$234K 0.37% 58
2017
Q3 		$1.86M Buy
151,760
+40,600
+37% +$718K 0.38% 56
2017
Q2 		$2.03M Buy
111,160
+120
+0.1% +$2.22K 0.44% 52
2017
Q1 		$2.35M Sell
111,040
-4,800
-4% -$93.7K 0.51% 50
2016
Q4 		$1.73M Buy
115,840
+65,200
+129% +$1.16M 0.39% 56
2016
Q3 		$1.11M Buy
50,640
+3,400
+7% +$75.7K 0.26% 68
2016
Q2 		$937K Buy
47,240
+3,320
+8% +$56.5K 0.23% 72
2016
Q1 		$746K Buy
+43,920
New +$734K 0.18% 77

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Marble Harbor Investment Counsel's DXCM Position: Q1 2026 in Review

Marble Harbor Investment Counsel increased its DexCom (DXCM) stake by 1.2% in Q1 2026, buying an estimated $100K and bringing the position to 125,012 shares worth $7.85M. The position accounts for 0.85% of the portfolio, ranked #40.

Marble Harbor Investment Counsel first reported a position in DXCM in Q1 2016 and has held it in 41 quarters since. The position peaked at $20.4M in Q1 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Marble Harbor Investment Counsel held 125,012 shares of DexCom worth $7.85M as of Q1 2026.
  • Marble Harbor Investment Counsel bought 1,440 DexCom shares in Q1 2026, an estimated $100K.
  • DexCom made up 0.85% of Marble Harbor Investment Counsel's portfolio in Q1 2026, its #40 holding.
  • Marble Harbor Investment Counsel first reported a position in DexCom in Q1 2016 and has held it in 41 quarters since.
  • Marble Harbor Investment Counsel's DexCom position peaked at $20.4M in Q1 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Marble Harbor Investment Counsel's 13F filing for Q1 2026, filed 8 May 2026.